CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		145,910
Beginning balance at Dec. 31, 2024	$ 2,492,737	$ 15	$ 3,921,432	$ (1,737)	$ (1,426,973)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)		1,226
Issuance of common stock pursuant to equity incentive plans	2,436		2,436
Stock-based compensation expense	95,494		95,494
Shares withheld for taxes related to net share settlement of equity awards (in shares)		(479)
Shares withheld for taxes related to net share settlement of equity awards	(38,508)		(38,508)
Foreign currency translation adjustment	981			981
Net income (loss)	(27,431)				(27,431)
Ending balance (in shares) at Mar. 31, 2025		146,657
Ending balance at Mar. 31, 2025	2,525,709	$ 15	3,980,854	(756)	(1,454,404)
Beginning balance (in shares) at Dec. 31, 2025		147,850
Beginning balance at Dec. 31, 2025	2,657,945	$ 15	4,145,485	1,039	(1,488,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)		1,273
Issuance of common stock pursuant to equity incentive plans	1,789		1,789
Stock-based compensation expense	78,682		78,682
Shares withheld for taxes related to net share settlement of equity awards (in shares)		(524)
Shares withheld for taxes related to net share settlement of equity awards	(51,520)		(51,520)
Repurchases and retirement of common stock (in shares)		(1,015)
Repurchases and retirement of common stock	(100,000)				(100,000)
Foreign currency translation adjustment	(1,532)			(1,532)
Net income (loss)	85,700				85,700
Ending balance (in shares) at Mar. 31, 2026		147,584
Ending balance at Mar. 31, 2026	$ 2,671,064	$ 15	$ 4,174,436	$ (493)	$ (1,502,894)